The circRNA circIFI30 promotes progression of triple-negative breast cancer and correlates with prognosis
Open Access
- 4 June 2020
- journal article
- research article
- Published by Impact Journals, LLC in Aging
- Vol. 12 (11), 10983-11003
- https://doi.org/10.18632/aging.103311
Abstract
Growing evidence suggests that circRNAs exert a critical role in tumorigenesis and cancer progression. To date, the molecular mechanisms underlying circRNAs in triple-negative breast cancer (TNBC) are still poorly known. Here, circRNA expression profile was investigated by RNA sequencing in TNBC tissues and matched para-carcinoma tissues. We found that circIFI30 was significantly up-regulated in TNBC tissues and cells using quantitative real-time PCR and in situ hybridization. High circIFI30 expression was positively correlated with clinical TNM stage, pathological grade and poor prognosis of TNBC patients. Functionally, a series of in vivo and in vitro experiments showed that knockdown of circIFI30 could markedly inhibit TNBC cell proliferation, migration, invasion and cell cycle progression, induce apoptosis as well as suppress tumorigenesis and metastasis. Up-regulation of circIFI30 exerted an opposite effect. Mechanistically, we demonstrated that circIFI30 might act as a competing endogenous RNA (ceRNA) of miR-520b-3p to abolish the suppressive effect on target gene CD44 by fluorescent in situ hybridization (FISH), dual luciferase reporter assay, RNA immunoprecipitation and RNA pull-down assays. Therefore, our work uncovers the mechanism by which circIFI30 could promote TNBC progression through circIFI30/miR-520b-3p/CD44 axis and circIFI30 could be a novel diagnostic/prognostic marker and therapeutic target for TNBC patients.Keywords
This publication has 35 references indexed in Scilit:
- Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathwayCancer Letters, 2017
- Targeting EphA2 impairs cell cycle progression and growth of basal-like/triple-negative breast cancersOncogene, 2017
- CD44: A Multifunctional Cell Surface Adhesion Receptor Is a Regulator of Progression and Metastasis of Cancer CellsFrontiers in Cell and Developmental Biology, 2017
- MiR-520b/e Regulates Proliferation and Migration by Simultaneously Targeting EGFR in Gastric CancerCellular Physiology and Biochemistry, 2016
- Molecular alterations in triple-negative breast cancer—the road to new treatment strategiesThe Lancet, 2016
- Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cellsInternational Journal of Molecular Medicine, 2015
- Evaluation of STAT3 Signaling in ALDH+ and ALDH+/CD44+/CD24− Subpopulations of Breast Cancer CellsPLOS ONE, 2013
- The Role of MicroRNAs in Breast Cancer Migration, Invasion and MetastasisInternational Journal of Molecular Sciences, 2012
- A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?Cell, 2011
- Targeting microRNAs in cancer: rationale, strategies and challengesNature Reviews Drug Discovery, 2010